Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
08 Maio 2023 - 9:00AM
Business Wire
Ringo and His Mother Will Reinforce the
Importance of Annual Mammograms
Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health,
today announced a partnership with recently drafted NFL cornerback
Kelee Ringo and his mother, breast cancer survivor Tralee Hale, to
educate women on the importance of prioritizing annual mammograms
and other key health screenings.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230508005184/en/
NFL cornerback Kelee Ringo and his
mother, breast cancer survivor Tralee Hale (Photo: Business
Wire)
Ringo is a two-time national champion from the University of
Georgia who was recently drafted by the Philadelphia Eagles. The
launch of the partnership with Hologic is timed with Mother’s Day
and National Women’s Health Week (May 14-20, 2023), when Ringo and
Hale will share the powerful story of Hale’s breast cancer
diagnosis, treatment and recovery.
Hale’s story is a familiar one: a woman who did not prioritize
her preventive care screenings as she focused on managing her
family, career and other commitments. As a single mother, she was
diagnosed with breast cancer just days after Ringo began his
freshman year in college. She is now cancer-free after completing
treatment, but Ringo and Hale know how lucky they are and want to
encourage women not to delay annual screenings.
“Kelee and Tralee’s story resonates with all of us because we
have heard from women — time and again — who have prioritized their
families and other responsibilities while putting their own health
screenings on the back burner,” said Erik Anderson, Hologic’s
Division President of Breast and Skeletal Health Solutions.
“Hearing how much they mean to one another and how this experience
impacted them was incredibly moving. We couldn’t be more grateful
that they are sharing their personal story as a way to reach women
about the critical importance of annual breast cancer screenings
and making their health a priority.”
Breast cancer is the most common cancer diagnosed among women in
the United States.1 However, recent studies show the rate of
routine breast cancer screenings has not fully bounced back after
sharp declines during the COVID-19 pandemic.2 Despite having a
similar incidence rate of this disease, Black women in the U.S. are
almost 40% more likely to die from breast cancer than non-Hispanic
white women.3
“As I launch my NFL career, I recognize and appreciate that I
have a real opportunity to use my platform to truly make a
difference,” said Ringo. “I’m excited to partner with Hologic on
this important campaign and thrilled to launch The Tralee &
Kelee Ringo Family Foundation to make a real impact on families
across the nation.”
The Tralee & Kelee Ringo Family Foundation will strive to
eradicate triple-negative breast cancer, a particularly aggressive
form of breast cancer that disproportionately affects women of
color.4 The foundation will work together with communities to
promote early detection and treatment to save lives. Its mission
will be pursued through equitable outreach, education, prevention
and treatment advancements.
Hologic, a pioneer in 3D mammography and creator of the Genius®
3D Mammography™ exam, is committed to increasing awareness about
the life-saving power of annual mammograms and other routine health
screenings. The partnership with Ringo and Hale will further that
impact through media interviews, public appearances and digital
content.
About Hologic Inc.
Hologic Inc. is a global medical technology innovator primarily
focused on improving women’s health and well-being through early
detection and treatment. Its advancements include invention of the
world’s first commercial 3D mammography system to find breast
cancer earlier; leadership in testing for cervical cancer, sexually
transmitted infections, respiratory illnesses and the virus that
causes COVID-19; and minimally invasive surgical technologies for
uterine fibroids and abnormal uterine bleeding.
The company also champions women through the Hologic Global
Women’s Health Index, which provides a science-backed data
framework for improving women’s well-being.
Hologic, Genius, 3D Mammography and The Science of Sure are
trademarks and/or registered trademarks of Hologic Inc. and/or its
subsidiaries in the United States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein or that such benefits
will be replicated in any particular manner with respect to an
individual patient, as the actual effect of the use of the products
can only be determined on a case-by-case basis. In addition, there
can be no assurance that these products will be commercially
successful or achieve any expected level of sales. Hologic
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statements presented
herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or
statements are based.
SOURCE: Hologic Inc.
1
https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html
2
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798851
3
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf
4
https://www.pennmedicine.org/news/news-releases/2021/september/black-women-face-three-fold-increased-risk-of-triple-negative-breast-cancers
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230508005184/en/
Media Contact: Bridget Perry Director, Divisional
Communications (+1) 508.263.8654 bridget.perry@hologic.com
Investor Contact: Ryan Simon Vice President, Investor
Relations (+1) 858.410.8514 ryan.simon@hologic.com
Hologic (NASDAQ:HOLX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Hologic (NASDAQ:HOLX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024